Edinburgh-based Resolution Therapeutics appointed Paul Sekhri as chair, replacing Lisa Bright.
PharmaDowning: Luke Stevenson
Investment manager Downing has appointed Luke Stevenson as associate director in its development capital team, which focuses on healthcare, education and housing and a small number of other specialist sectors
Stevenson joins from pan-European healthcare private equity investor, G Square, where he sourced new deals and executed transactions, alongside ongoing portfolio management roles to support a variety of UK and global healthcare businesses. Before that, he worked in the M&A advisory team at Jefferies International and in investment banking at HSBC.
Mark Gross, partner and head of development capital at Downing, said: “We are excited to welcome Luke as we continue to expand our team and investment activities. We feel Luke’s investment experience, sector focus and approach to collaborative working are well matched with Downing’s investment strategy and style.”
Stevenson added: “Downing’s development capital team is highly regarded, having built an attractive portfolio of investments and a strong track record of returns. I look forward to joining the business as it continues to grow and to working alongside colleagues, prospective management teams and portfolio companies to deliver for our investors.”
Latest Executive Moves
Broken String Biosciences, has appointed Laurence Reid as chairman, and Brad Crutchfield as a non-executive director.
PharmaCare home provider Signature Senior Lifestyle has appointed Vishul Seewoolall as chief operating officer.
Social care